1711440
Verapamil Related Compound F
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 93-03-8
Synonym(S): 3,4-Dimethoxybenzyl alcohol, Veratryl alcohol
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 150 MG | 1711440-150-MG | In Stock | ₹ 1,29,412.88 |
1711440 - 150 MG
In Stock
Quantity
1
Base Price: ₹ 1,29,412.88
GST (18%): ₹ 23,294.318
Total Price: ₹ 1,52,707.198
grade
pharmaceutical primary standard
API family
verapamil
manufacturer/tradename
USP
refractive index
n20/D 1.552 (lit.)
bp
296-297 °C/732 mmHg (lit.)
density
1.157 g/mL at 25 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
COc1ccc(CO)cc1OC
InChI
1S/C9H12O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5,10H,6H2,1-2H3
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 3,4-Dimethoxybenzyl alcohol | Sigma Aldrich | ₹ 4,611.45 - ₹ 15,901.93 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Verapamil Related Compound F USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: verapamil
manufacturer/tradename: USP
refractive index: n20/D 1.552 (lit.)
bp: 296-297 °C/732 mmHg (lit.)
density: 1.157 g/mL at 25 °C (lit.)
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: COc1ccc(CO)cc1OC
InChI: 1S/C9H12O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5,10H,6H2,1-2H3
grade:
pharmaceutical primary standard
API family:
verapamil
manufacturer/tradename:
USP
refractive index:
n20/D 1.552 (lit.)
bp:
296-297 °C/732 mmHg (lit.)
density:
1.157 g/mL at 25 °C (lit.)
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
COc1ccc(CO)cc1OC
InChI:
1S/C9H12O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5,10H,6H2,1-2H3
grade: pharmaceutical primary standard
API family: __
manufacturer/tradename: USP
refractive index: __
bp: __
density: __
application(s): pharmaceutical
format: neat
SMILES string: C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O
InChI: 1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1
grade:
pharmaceutical primary standard
API family:
__
manufacturer/tradename:
USP
refractive index:
__
bp:
__
density:
__
application(s):
pharmaceutical
format:
neat
SMILES string:
C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O
InChI:
1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1
grade: pharmaceutical primary standard
API family: verteporfin
manufacturer/tradename: USP
refractive index: __
bp: __
density: __
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: CC(C(/C=C1[C@@]2(C)C(/C(N/1)=C/3)=CC=C(C(OC)=O)[C@H]2C(OC)=O)=N/4)=C(CCC(OC)=O)C4=C\C5=C(CCC(O)=O)C(C)=C(/C=C6C(C=C)=C(C)C3=N/6)N5.CC(C(/C=C7[C@@]8(C)C(/C(N/7)=C/9)=CC=C(C(OC)=O)[C@H]8C(OC)=O)=N/%10)=C(CCC(O)=O)C%10=C\C%11=C(CCC(OC)=O)C(C)=C(/C=C%12C(C=C)
InChI: 1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,43,45H,1,11-12,14-15H2,2-8H3,(H,46,47)/b31-16-,32-18-,34-17-,35-19-;31-16-,33-18-,34-17-,35-19-/t2*38-,41+/m00/s1
grade:
pharmaceutical primary standard
API family:
verteporfin
manufacturer/tradename:
USP
refractive index:
__
bp:
__
density:
__
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
CC(C(/C=C1[C@@]2(C)C(/C(N/1)=C/3)=CC=C(C(OC)=O)[C@H]2C(OC)=O)=N/4)=C(CCC(OC)=O)C4=C\C5=C(CCC(O)=O)C(C)=C(/C=C6C(C=C)=C(C)C3=N/6)N5.CC(C(/C=C7[C@@]8(C)C(/C(N/7)=C/9)=CC=C(C(OC)=O)[C@H]8C(OC)=O)=N/%10)=C(CCC(O)=O)C%10=C\C%11=C(CCC(OC)=O)C(C)=C(/C=C%12C(C=C)
InChI:
1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,43,45H,1,11-12,14-15H2,2-8H3,(H,46,47)/b31-16-,32-18-,34-17-,35-19-;31-16-,33-18-,34-17-,35-19-/t2*38-,41+/m00/s1
grade: pharmaceutical primary standard
API family: verteporfin
manufacturer/tradename: USP
refractive index: __
bp: __
density: __
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: __
InChI: __
grade:
pharmaceutical primary standard
API family:
verteporfin
manufacturer/tradename:
USP
refractive index:
__
bp:
__
density:
__
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
__
InChI:
__